Jacobi Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$1K 1484
2020
Q4
$1K Hold
100
﹤0.01% 1288
2020
Q3
$1K Hold
100
﹤0.01% 1238
2020
Q2
$1K Hold
100
﹤0.01% 1209
2020
Q1
$1K Hold
100
﹤0.01% 1116
2019
Q4
$1K Hold
100
﹤0.01% 1051
2019
Q3
$1K Hold
100
﹤0.01% 1031
2019
Q2
$1K Hold
100
﹤0.01% 1023
2019
Q1
$1K Hold
100
﹤0.01% 964
2018
Q4
$1K Hold
100
﹤0.01% 944
2018
Q3
$2K Hold
100
﹤0.01% 917
2018
Q2
$2K Hold
100
﹤0.01% 947
2018
Q1
$2K Hold
100
﹤0.01% 915
2017
Q4
$2K Hold
100
﹤0.01% 869
2017
Q3
$1K Hold
100
﹤0.01% 887
2017
Q2
$2K Hold
100
﹤0.01% 780
2017
Q1
$2K Hold
100
﹤0.01% 655
2016
Q4
$2K Hold
100
﹤0.01% 572
2016
Q3
$2K Hold
100
﹤0.01% 669
2016
Q2
$3K Buy
+100
New +$2.78K ﹤0.01% 617

Jacobi Capital Management's ARA Position: Q1 2021 in Review

Jacobi Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 100 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $3K in Q2 2016. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Jacobi Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 100 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
  • Jacobi Capital Management's American Renal Associates Holdings, Inc position peaked at $3K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Jacobi Capital Management's 13F filing for Q1 2021, filed 11 May 2021.